Yatharth Hospital Board approves Q1FY26 results, appoints & re-appoints auditors.
The financial results and auditor appointments are relevant for investors, but not transformative.
The announcement includes approval of financial results and key appointments, indicating ongoing operations and governance.
* Approved Un-audited Financial Results (Standalone and Consolidated) for Q1 ended June 30, 2025. * Appointed M/s MKP & Associates as Secretarial Auditor for 5 years, starting April 1, 2025, subject to shareholder approval. * Re-appointed M/s Subodh Kumar & Co. as Cost Auditor for FY 2025-26. * Appointed M/s Saurav Upadhyay & Associates as Scrutinizer for the upcoming Annual General Meeting (AGM). * Standalone revenue from operations for the quarter ended June 30, 2025, was ₹1,301.44 million. * Consolidated revenue from operations for the quarter was ₹2,577.71 million. * Net Profit after tax (Consolidated) was ₹420.41 million. * The company inaugurated its Model Town facility on July 14, 2025, and commenced commercial operations.
What to do with a filing like this
Yatharth Hospital & Trauma Care Services Limited filed this with the NSE as a statutory disclosure, categorised under results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Yatharth Hospital & Trauma Care Services Limited. Read the original for the full detail.